Geoffrey P Kempler
Follow
Get notifications in MyBN when activity occurs.
Geoffrey P Kempler
Executive Chairman, Chief Executive Officer / Alterity Therapeutics
Mr Kempler has served as our Chief Executive Officer, and in June 2005 he again assumed the position of Chief Executive Officer. Mr Kempler has experience in investment and business development, has been in charge for the implementation of our strategic plan and the commercialisation of our technology.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 683rd | Respiri | 0% | 0% |
| 1257th | Mediland Pharm | -36% | -15% |
| 1389th | Alterity Therapeutics | -45% | -34% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 881st |  | Alterity Therapeutics | $3.9m |
| 1030th | | Ansarada Group | $721k |
| 1031st | | Cann Global | $701k |
| 1035th | | Respiri | $662k |
| 1036th | | Mediland Pharm | $662k |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
 | NEW ROLE: Executive Chairman, Chief Executive Officer, Alterity Therapeutics | 03 Nov 2020 |
